WGS of histological samples from NSCLC tumors that underwent SCLC transformation under EGFR-TKI treatment revealed complete inactivation of tumor-suppressing genes (RB1, TP53) in both the initial NSCLC and at the newly detected SCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.